94 related articles for article (PubMed ID: 5530668)
21. Drug ads: how much is hype?
Johns Hopkins Med Lett Health After 50; 2001 Nov; 13(9):1-2. PubMed ID: 11682901
[No Abstract] [Full Text] [Related]
22. AAFP supports improvement, not ban, on direct-to-consumer prescription drug ads.
Kellerman R;
Ann Fam Med; 2007; 5(2):180-1. PubMed ID: 17389544
[No Abstract] [Full Text] [Related]
23. [Fundamental problems in the testing of antidepressive agents].
Immich H; Eckmann F; Neumann H; Schäpperle O; Schwarz H; Tempel H
Arzneimittelforschung; 1971 Apr; 21(4):525-8. PubMed ID: 5108155
[No Abstract] [Full Text] [Related]
24. [Pharmaceutic promotion and publicity: quo vadis?].
Castillo Pérez P
Med Clin (Barc); 1992 Sep; 99(8):305-9. PubMed ID: 1453825
[No Abstract] [Full Text] [Related]
25. Regulating pharmaceutical advertising: what will work?
Shapiro MF
CMAJ; 1997 Feb; 156(3):359-61. PubMed ID: 9033416
[TBL] [Abstract][Full Text] [Related]
26. Antidepressants in bipolar depression.
Vieta E
Acta Psychiatr Scand; 2008 Nov; 118(5):335-6. PubMed ID: 18855837
[No Abstract] [Full Text] [Related]
27. Sin of omission? Pharmaceutical trade group failed to disclose that ad subject was employee.
Becker C
Mod Healthc; 2001 Aug; 31(32):5, 8. PubMed ID: 11507868
[No Abstract] [Full Text] [Related]
28. Ethical code of the pharmaceutical industry in Slovakia. (Excerpts).
Med Etika Bioet; 2004; 11(3-4):11-22. PubMed ID: 16294449
[No Abstract] [Full Text] [Related]
29. Trying to keep faith in humanity.
Feigenbaum NL
Pract Periodontics Aesthet Dent; 1996 Mar; 8(2):124. PubMed ID: 9028285
[No Abstract] [Full Text] [Related]
30. Standards for pharmaceutical advertising in Canada.
Chepesiuk R
CMAJ; 2005 Aug; 173(3):238; author reply 238. PubMed ID: 16076811
[No Abstract] [Full Text] [Related]
31. Pharmaceutical advertising in ophthalmology.
Kahawita SK; Casson RJ
Clin Exp Ophthalmol; 2012 Mar; 40(2):216-7. PubMed ID: 21902791
[No Abstract] [Full Text] [Related]
32. [Depression--a gender-disease in drug advertisement].
Sandström L; Johansson EE
Lakartidningen; 2004 Feb; 101(7):582-5. PubMed ID: 15024868
[No Abstract] [Full Text] [Related]
33. Complaints about advertising of medicines are encouraged.
Simmonds H
BMJ; 2002 Apr; 324(7341):850-1. PubMed ID: 11934787
[No Abstract] [Full Text] [Related]
34. Commentary: advertising adversities.
Christo GG; Balasubramaniam R
BMJ; 1997 Aug; 315(7106):460. PubMed ID: 9284663
[No Abstract] [Full Text] [Related]
35. Direct consumer advertising of prescription drugs.
Whyte J
JAMA; 1993 Jan; 269(1):146, 150. PubMed ID: 8355365
[No Abstract] [Full Text] [Related]
36. Misrepresenting an ASHP practice standard for commercial purposes.
Myers CE
Am J Hosp Pharm; 1994 Sep; 51(17):2107-8. PubMed ID: 7985684
[No Abstract] [Full Text] [Related]
37. [On ethical issues of pharmaceutical communication. National Association of Hungarian Pharmaceutical Manufacturers and Wholesalers].
Kata M; Sánta Z
Orv Hetil; 1994 Oct; 135(42):2343-7. PubMed ID: 7970650
[No Abstract] [Full Text] [Related]
38. [Alcohol and tonic--a suitable remedy?].
Allander E
Lakartidningen; 1968 Feb; 65(6):543-8. PubMed ID: 5723554
[No Abstract] [Full Text] [Related]
39. Recent progress in drug advertising.
McElwain M
Can Fam Physician; 1997 Jun; 43():1041-2. PubMed ID: 9189283
[No Abstract] [Full Text] [Related]
40. [Problems of masked depressions].
Radmayr E
Wien Klin Wochenschr; 1971 May; 83(19):333-4. PubMed ID: 5556372
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
